Vera Therapeutics, Inc. - Class A (VERA) is listed on NASDAQ in Pharmaceutical Stocks. It is $34.17, -1.24%, with a $2.5B market cap. RSI is 49.9, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 49.9 Neutral
Market Cap $2.5B
Volume 1.1M
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-230.5M
EPS $-3.22
Debt / Equity 0.2x
P/E Ratio -10.6x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Fordyce Marshall | PRESIDENT AND CEO | Sell | 46,250 | $42.30 | $2.0M | 2026 Jul 7 |
| Fordyce Marshall | PRESIDENT AND CEO | Sell | 46,250 | $42.30 | $2.0M | 2026 Jul 7 |
| Fordyce Marshall | PRESIDENT AND CEO | Sell | 18,500 | $37.93 | $701,769 | 2026 Jun 23 |
| Fordyce Marshall | PRESIDENT AND CEO | Sell | 18,500 | $37.93 | $701,769 | 2026 Jun 23 |
| Fordyce Marshall | PRESIDENT AND CEO | Sell | 18,500 | $36.74 | $679,747 | 2026 May 12 |
| Fordyce Marshall | PRESIDENT AND CEO | Sell | 18,500 | $36.74 | $679,747 | 2026 May 12 |
| Fordyce Marshall | PRESIDENT AND CEO | Sell | 22,951 | $44.05 | $1.0M | 2026 Apr 14 |
| Brenner Robert | Chief Medical Officer | Sell | 2,151 | $41.98 | $90,307 | 2026 Feb 23 |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 3,117 | $41.98 | $130,864 | 2026 Feb 23 |
| Grant Sean | CHIEF FINANCIAL OFFICER | Sell | 4,949 | $41.98 | $207,778 | 2026 Feb 23 |
| Fordyce Marshall | PRESIDENT AND CEO | Sell | 16,925 | $41.98 | $710,578 | 2026 Feb 23 |
| Johnson David Lee | Chief Operating Officer | Sell | 2,579 | $41.98 | $108,276 | 2026 Feb 23 |
| Turner William D. | Chief Regulatory Officer | Sell | 2,187 | $41.98 | $91,819 | 2026 Feb 23 |
| Skelton Laurence Matthew | Chief Commercial Officer | Sell | 1,582 | $41.98 | $66,419 | 2026 Feb 23 |
| Turner William D. | Chief Regulatory Officer | Sell | 10,000 | $50.08 | $500,800 | 2025 Dec 15 |
| Enright Patrick G | Director | Buy | 5,882 | $42.50 | $249,985 | 2025 Dec 11 |
| Turner William D. | Chief Regulatory Officer | Sell | 10,000 | $45.31 | $453,100 | 2025 Dec 8 |
| Turner William D. | Chief Regulatory Officer | Sell | 10,000 | $40.00 | $400,000 | 2025 Dec 3 |
| Carter Jason S | Chief Legal Officer | Sell | 3,864 | $27.82 | $107,496 | 2025 Nov 21 |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 15,000 | $29.06 | $435,900 | 2025 Nov 11 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $84.85 | 71.8 | $9.0B |
| | $24.11 | 48.8 | $12.0B |
| | $345.04 | 48.5 | $9.6B |
| | $61.02 | 60.3 | $10.1B |
Take VERA further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put VERA in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Vera Therapeutics, Inc. - Class A next reports.
Set alerts on VERA
Get notified when Vera Therapeutics, Inc. - Class A hits your price targets or technical conditions are met.
Get Started Free